CHEN Zerun
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, ChinaGUO Jishen
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, ChinaFENG Jiaxin
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, ChinaHU Yating
School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, ChinaOU Tao
School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, ChinaZHU Jiening
Guangdong Cardiovascular Institute, Guangzhou, Guangdong 510080, ChinaLI Hui
Research Center of Medical Sciences, Guangdong Provincial People’s Hospital, Guangzhou, Guangdong 510080, ChinaXU Jindong
Research Center of Medical Sciences, Guangdong Provincial People’s Hospital, Guangzhou, Guangdong 510080, ChinaFANG Xianhong
Guangdong Cardiovascular Institute, Guangzhou, Guangdong 510080, ChinaSHAN Zhixin
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, China;Research Center of Medical Sciences, Guangdong Provincial People’s Hospital, Guangzhou, Guangdong 510080, China1.The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, China;2.School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, China;3.School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China;4.Guangdong Cardiovascular Institute, Guangzhou, Guangdong 510080, China;5.Research Center of Medical Sciences, Guangdong Provincial People’s Hospital, Guangzhou, Guangdong 510080, China)
R329.21; R5
CHEN Zerun, GUO Jishen, FENG Jiaxin, HU Yating, OU Tao, ZHU Jiening, LI Hui, XU Jindong, FANG Xianhong, SHAN Zhixin. Circular RNA circ_ 0036167 combined with fused in sarcoma to inhibit the fibrotic phenotype of cardiac fibroblasts[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(2):101-109.
Copy